Clinical trial
Verification of a Pharmacogenetic Approach to Customizing Chemotherapy to Asians
NCT01596361 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Verification of a Pharmacogenetic Approach to Customizing Chemotherapy to Asians
- Lead sponsor
- National University Hospital, Singapore
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2011
- Completion date
- Not reported
- Enrollment
- 750 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer